Our automation platform in Lille has now a name ! We call it HAPIx for “HCS Automation Platform for Imaging”. And what is this little “x” besides ? It means that we can take 3D pictures of many things like cells, spheroids, skin, histology slides, etc.

To achieve this, we use two very powerful confocal acquisition tools from Molecular Devices (ImageXpress Micro Confocal) and a robust software layer to work in a high throughput manner. Thanks to a strong partnership with Molecular Devices, we are able to use the latest software developments and profit from their best skills ! It is a good way to imagine how to be better and simpler for our customers !

As it could be complicated to imagine what an automation platform is, we are happy to share with you a short immersive video “inside” HAPIx ! If you want to experiment it, please use a Google cardboard or something similar.

Grégory MAUBON

Grégory MAUBON is Chief Data Officer and digital coordinator at HCS Pharma, a biotech startup focused in high content screening and complex diseases. He manages IT missions and leads digital usages linked to company needs. He is also a Augmented Reality Evangelist (presenter and lecturer) since 2008, where he created www.augmented-reality.fr and founded in 2010 RA'pro (the augmented reality promotion association). He helped many companies (in several domains) to define precisely their augmented reality needs and supported them in the implementation.


Great symposium at Drug Discovery 2017 ! | HCS-pharma · October 16, 2017 at 3:13 pm

[…] genotoxicity. In addition, visitors of our booth really enjoyed the 3D virtual reality visit of our new facilities in Lille […]

See you next week on BioFIT 2017 event in Strasbourg! | HCS-pharma · November 22, 2017 at 4:22 pm

[…] will present our new robotic platform, HAPIx, dedicated to HCS and our new assays, especially on genotoxicity analysis (mutiparametric assay […]

Ready to ELRIGfr Monaco with a special workshop on augmented reality ? | HCS-pharma · November 22, 2017 at 8:10 pm

[…] integration and training. Of course, we will talk about our use of augmented reality for our HAPIx installation […]

Interested by e-health? Join us at BPI France to be informed about the last innovations from CES 2019! | HCS Pharma · January 17, 2019 at 2:26 pm

[…] involved in the use and development of digital for healthcare because we are used to work with robots, machine learning, augmented and virtual reality, data mining, IoT monitoring devices, etc. By […]

We will be at SLAS 2018 "Advanced 3D Human Models and High-Content Analysis Conference" | HCS Pharma · November 30, 2020 at 11:09 am

[…] In HCS Pharma we strongly believe that 3D is the right way to improve drugs dicovery processes. It’s why we develop our 3D hydroscaffold matrix BIOMIMESYS® for 3D cell culture and we invest in 3D pictures acquisition (and analyse) with our partner Molecular Devices. […]

Great symposium at Drug Discovery 2017 ! | HCS Pharma · November 30, 2020 at 11:20 am

[…] genotoxicity. In addition, visitors of our booth really enjoyed the 3D virtual reality visit of our new facilities in Lille […]

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.